Guerbet

This study tested the safety and effectiveness of a procedure that uses a special oil (Lipiodol) mixed with surgical glue to block off abnormal blood vessels. The procedure, called embolization, was performed on 132 adults with conditions like hemangiomas, angiosarcoma, or arteri…

This completed trial tested whether a new MRI contrast agent called Elucirem could produce clearer images of brain tumors compared to an existing agent called Dotarem. The study involved 138 adults with primary or recurrent brain gliomas who underwent specialized MRI scans. Resea…

This trial tested a new dye (gadopiclenol) injected during MRI scans to see if it helps doctors get clearer pictures of brain lesions, like tumors. It involved 260 patients worldwide who each received two MRI scans: one with the new dye and one with a standard dye. The main goal …

This trial tested a new dye (gadopiclenol) used during MRI scans to see if it helps doctors see body lesions more clearly than scans without dye. It also compared it to an existing dye (gadobutrol). Over 300 patients with known or suspected body lesions each received two MRIs, on…

This study aimed to understand how a new contrast agent (a special dye) for MRI scans is processed by the body in very young children. It involved 36 infants under 2 years old who needed an MRI. Researchers gave a single dose and took blood samples to measure how long the agent s…